Literature DB >> 22249700

[Irreversible electroporation - a new kid on the block?].

O Kosiek1, K Strach, J Ricke, M Pech.   

Abstract

CLINICAL/METHODICAL ISSUE: Minimally invasive tumor therapies are well established options in multi-modal oncological therapy regimes. So far the methods applied have been of a thermal nature and thus there are inherent limitations, most of all the so-called heat-sink effect. STANDARD RADIOLOGICAL
METHODS: Radiofrequency ablation (RFA) and laser-induced thermotherapy (LITT) are well-established techniques. METHODICAL INNOVATIONS: Irreversible electroporation (IRE) could potentially become a novel therapy option with an enlarged spectrum of treatable lesions, i.e. close to blood vessels and potentially a lower rate of complications. PERFORMANCE: The IRE technique is currently the subject of early prospective trials and clinical studies have not yet shown any serious side effects. However, complete tumor ablation was not achieved in all cases (46 out of 69). ACHIEVEMENTS: Preclinical as well as clinical studies seem to show a promising efficiency in tumor ablation as well as a favorable complication profile especially with tumors in thermally critical locations. PRACTICAL RECOMMENDATIONS: Clinical long-term studies are currently under way assessing safety as well as efficiency. The data published so far look promising and considerably enlarge the spectrum of ablation techniques.

Entities:  

Mesh:

Year:  2012        PMID: 22249700     DOI: 10.1007/s00117-011-2210-2

Source DB:  PubMed          Journal:  Radiologe        ISSN: 0033-832X            Impact factor:   0.635


  18 in total

1.  Angiography in the isolated perfused kidney: radiological evaluation of vascular protection in tissue ablation by nonthermal irreversible electroporation.

Authors:  Johann Jakob Wendler; Maciej Pech; Simon Blaschke; Markus Porsch; Andreas Janitzky; Matthias Ulrich; Oliver Dudeck; Jens Ricke; Uwe-Bernd Liehr
Journal:  Cardiovasc Intervent Radiol       Date:  2011-06-02       Impact factor: 2.740

2.  Imaging guided percutaneous irreversible electroporation: ultrasound and immunohistological correlation.

Authors:  Edward W Lee; Christopher T Loh; Stephen T Kee
Journal:  Technol Cancer Res Treat       Date:  2007-08

3.  Irreversible electroporation: implications for prostate ablation.

Authors:  Gary Onik; Paul Mikus; Boris Rubinsky
Journal:  Technol Cancer Res Treat       Date:  2007-08

4.  Irreversible electroporation near the heart: ventricular arrhythmias can be prevented with ECG synchronization.

Authors:  Ajita Deodhar; Timm Dickfeld; Gordon W Single; William C Hamilton; Raymond H Thornton; Constantinos T Sofocleous; Majid Maybody; Mithat Gónen; Boris Rubinsky; Stephen B Solomon
Journal:  AJR Am J Roentgenol       Date:  2011-03       Impact factor: 3.959

5.  Acute and subacute effects of irreversible electroporation on nerves: experimental study in a pig model.

Authors:  Helmut Schoellnast; Sebastien Monette; Paula C Ezell; Ajita Deodhar; Majid Maybody; Joseph P Erinjeri; Michael D Stubblefield; Gordon W Single; William C Hamilton; Stephen B Solomon
Journal:  Radiology       Date:  2011-06-03       Impact factor: 11.105

6.  Irreversible electroporation of the pancreas: definitive local therapy without systemic effects.

Authors:  Matthew Bower; Leslie Sherwood; Yan Li; Robert Martin
Journal:  J Surg Oncol       Date:  2011-02-28       Impact factor: 3.454

7.  Renal tissue ablation with irreversible electroporation: preliminary results in a porcine model.

Authors:  Ajita Deodhar; Sébastien Monette; Gordon W Single; William C Hamilton; Raymond Thornton; Majid Maybody; Jonathan A Coleman; Stephen B Solomon
Journal:  Urology       Date:  2010-12-15       Impact factor: 2.649

8.  Mathematical modeling of irreversible electroporation for treatment planning.

Authors:  Jon F Edd; Rafael V Davalos
Journal:  Technol Cancer Res Treat       Date:  2007-08

9.  The effect of irreversible electroporation on blood vessels.

Authors:  Elad Maor; Antoni Ivorra; Jonathan Leor; Boris Rubinsky
Journal:  Technol Cancer Res Treat       Date:  2007-08

10.  The fluid mosaic model of the structure of cell membranes.

Authors:  S J Singer; G L Nicolson
Journal:  Science       Date:  1972-02-18       Impact factor: 47.728

View more
  2 in total

Review 1.  [Irreversible electroporation. Current value for focal treatment of prostate cancer].

Authors:  J J Wendler; R Ganzer; B Hadaschik; A Blana; T Henkel; K U Köhrmann; S Machtens; A Roosen; G Salomon; L Sentker; U Witzsch; H P Schlemmer; D Baumunk; J Köllermann; M Schostak; U B Liehr
Journal:  Urologe A       Date:  2015-06       Impact factor: 0.639

Review 2.  [Focal therapy of prostate cancer in Germany].

Authors:  M Apfelbeck; A Herlemann; C G Stief; C Gratzke
Journal:  Urologe A       Date:  2016-05       Impact factor: 0.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.